Artiva Biotherapeutics, Inc. Expense Breakdown
No Expense Breakdown for ARTV on this site yet.
- 2026-06-30: Personnel-Related $10.88M; Service, Other $4.13M.
- 2025-06-30: Personnel-Related $9.64M; Service, Other $4.48M.
Source checked: the stored Expense Breakdown page for ARTV.
Expenses by product
Operating expenses: each quarter (3 month)
| Quarter end | Personnel-Related | Service, Other |
|---|---|---|
| 2026-06-30 | $10.88M | $4.13M |
| 2025-06-30 | $9.64M | $4.48M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |